EZH2 and colitis: In this case, while global inhibition of EZH2 activity or myeloid-specific Ezh2 deletion ameliorates experimental intestinal inflammation [39] the loss of Ezh2 in either the intestinal epithelium [15] or regulatory T cells [7] results in a spontaneous colitis phenotype.